4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001662579-23-000035
Chief Financial Officer acquired 26,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| White Lauren Chief Financial Officer | 2023-02-13 | Grant or award | +26,000 | 31,097 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| White Lauren Chief Financial Officer | 2023-02-13 | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | D: show line 2 in the form |
Loading xslF345X03/wf-form4_167649747523081.xml…